Cite
HARVARD Citation
Lyskjær, I. et al. (2021). Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations. Molecular oncology. 15 (12), pp. 3679-3690. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lyskjær, I. et al. (2021). Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations. Molecular oncology. 15 (12), pp. 3679-3690. [Online].